Transcripts Astellas Pharma Inc. Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 15:41:05 2024-06-28 EDT			5-day change	1st Jan Change
9.016 ^EUR	-0.68%		+2.88%	-17.89%

06-03	US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab	MT
05-31	U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date	CI

Transcript : Astellas Pharma Inc., 2024 Earnings Call, Apr 25, 2024	04-25
Transcript : Astellas Pharma Inc. - Special Call	02-20
Transcript : Astellas Pharma Inc., Q3 2024 Earnings Call, Feb 05, 2024	02-05
Transcript : Astellas Pharma Inc. - Special Call	11-05
Transcript : Astellas Pharma Inc., Q2 2024 Earnings Call, Nov 01, 2023	11-01
Transcript : Astellas Pharma Inc., Q1 2024 Earnings Call, Aug 01, 2023	23-08-01
Transcript : Astellas Pharma Inc., IVERIC bio, Inc. - M&A Call	23-04-30
Transcript : Astellas Pharma Inc., 2023 Earnings Call, Apr 27, 2023	23-04-27
Transcript : Astellas Pharma Inc. - Special Call	23-03-27
Transcript : Astellas Pharma Inc. - Special Call	23-02-17
Transcript : Astellas Pharma Inc., Q3 2023 Earnings Call, Feb 06, 2023	23-02-06
Transcript : Astellas Pharma Inc. - Special Call	22-12-08
Transcript : Astellas Pharma Inc., Q2 2023 Earnings Call, Oct 31, 2022	22-10-31
Transcript : Astellas Pharma Inc. - Special Call	22-10-16
Transcript : Astellas Pharma Inc., Q1 2023 Earnings Call, Aug 01, 2022	22-08-01
Transcript : Astellas Pharma Inc., 2022 Earnings Call, Apr 27, 2022	22-04-27
Transcript : Astellas Pharma Inc. - Special Call	22-03-08
Transcript : Astellas Pharma Inc. - Special Call	22-02-28
Transcript : Astellas Pharma Inc., Q3 2022 Earnings Call, Feb 02, 2022	22-02-02
Astellas Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022	22-02-01	CI

No results for this search